| Financial Year |
March 31 2023 |
| Monetary Funds |
509,212,042.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
359,793,382.18 |
| Advances to Suppliers |
21,136,357.78 |
| Other Receivables |
34,360,657.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,332,215.65 |
| Dividend Receivable |
-- |
| Inventories |
31,407,695.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,340,309.41 |
| Total Current Assets |
976,152,120.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,592,814.56 |
| Long-term Equity Investment |
462,252,661.00 |
| Investment Properties |
565,291,955.46 |
| Fixed Assetes |
185,031,641.24 |
| Under-construction Projects |
180,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,459,998.80 |
| R&D expenses |
-- |
| Goodwill |
420,734,760.91 |
| Long-Term Deferred and Prepaid Expenses |
3,804,736.28 |
| Deferred Income Tax Assets |
38,903,556.33 |
| Other Non-Current Assets |
445,301,033.55 |
| Sub-Total of Non-Current Assets |
2,885,334,381.07 |
| Total Assets |
3,861,486,501.39 |
| Short-Term Loans |
105,863,734.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
75,423,317.79 |
| Accounts Received In Advance |
161,333.43 |
| Employee Compensation Payable |
17,956,242.28 |
| Taxes Payable |
20,030,653.81 |
| Interest Payable |
8,158.35 |
| Dividend Payable |
3,533,392.62 |
| Other payables |
294,790,340.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,414,316.26 |
| Other Current Liabilities |
988,984.78 |
| Sub-Total of Current Liabilities |
532,092,173.87 |
| Long-term Loans |
6,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,067,303.34 |
| Deferred Income Tax Liabilities |
100,979,703.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
112,605,917.89 |
| Total Liabilities |
644,698,091.76 |
| Paid-In Capital(Or Share Stock) |
1,093,332,092.00 |
| Capital Surplus |
853,981,238.66 |
| Surplus Reserve |
355,529,886.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
694,776,619.08 |
| Minority Stockholder's Interest |
198,364,581.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,018,423,828.28 |
| Owner's Equity（Stockholder's Equity） |
3,216,788,409.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,861,486,501.39 |
